Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery1, Mike Briley2 1Imperial College School of Medicine, London, England, UK; 2NeuroBiz Consulting and Communication, Castres, FranceMilnacipran: recent findings in depressionMilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) which was first approved for the treatm...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-08-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/editorial-foreword---milnacipran-recent-findings-in-depression-a5108 |